WEGE KLINIK
WEGE Klinik is a Bonn-based specialized oncology clinic and one of Germany's largest bed-carrying radiotherapy centers, delivering radiotherapy, interventional radiology, radiosurgery, brachytherapy, and palliative medicine to statutory and privately insured cancer patients under parent Mercurius Health Group.
- Company typePrivate
- Founded1937
- HeadquartersBonn, Germany
- Headcount11–50
- GTM typeB2C
- OfferingServices
What WEGE KLINIK does
WEGE Klinik, headquartered at Villenstraße 8 in Bonn, Germany, is a specialized oncology and radiation therapy clinic that operates as one of the largest bed-carrying radiotherapy facilities in Germany. Originally founded in 1937 as the Robert-Janker-Klinik by radiologist Robert Janker, the clinic was part of MediClin AG from 1998 before being acquired by Mercurius Health Group in January 2023 and rebranded as WEGE-Klinik in December 2024. The clinic treats cancer patients with solid tumors across radiotherapy and radiation oncology, diagnostic and interventional radiology, neuroradiology, stereotactic radiosurgery, brachytherapy (HDR and LDR), electrochemotherapy, and palliative medicine, serving both statutory (gesetzlich) and privately insured patients through inpatient beds and the affiliated WEGE MVZ outpatient Medical Care Center.
The clinic's technical differentiation rests on a small set of unique equipment combinations available at very few sites in Germany: the Brainlab ExacTrac Dynamic 2.0 paired with an Elekta Versa HD linear accelerator for sub-millimeter precision radiotherapy (present at only three German clinics), and the Philips Spectral CT 7500 paired with CAS-One IR stereotactic navigation for minimally invasive interventional oncology (the first such installation in Germany). It supports IMRT, VMAT, IGRT, HDR/LDR brachytherapy, embolization, and CT-navigated fusion biopsies, and is credited with pioneering work in electrochemotherapy combined with spectral and stereotactic control. The clinic is led by three chief physicians (Prof. Pinkawa in radiotherapy and radiooncology, Prof. Kovács in diagnostic and interventional radiology/neuroradiology, Dr. Cuhls in palliative medicine), with additional internationally recognized specialists Prof. Jan Boström and PD Dr. Azize Boström in the MVZ.
WEGE Klinik generates revenue through inpatient hospital services and outpatient clinic services billed via the German statutory and private health insurance system, supplemented by overregional patient referrals and direct inquiries. Patient acquisition is driven primarily by physician referrals (gastroenterologists, surgeons, oncologists), tumor board recommendations, and clinical reputation, supported by educational content, the international Drei-Länder-Symposium für Brachytherapie, and earned media coverage including the Focus Gesundheit Top-Mediziner 2025 recognition. Mercurius Health Group has committed up to €20 million in medium-term investment to transform WEGE Klinik into a flagship European oncology center.
WEGE KLINIK firmographics
Firmographics- Name
- WEGE KLINIK
- Legal name
- WEGE Klinik GmbH & Co. KG
- Website
- https://wegeklinik.com
- Company type
- Private
- Founded year
- 1937
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- WEGE Klinik is a Bonn-based specialized oncology clinic and one of Germany's largest bed-carrying radiotherapy centers, delivering radiotherapy, interventional radiology, radiosurgery, brachytherapy, and palliative medicine to statutory and privately insured cancer patients under parent Mercurius Health Group.
- Ownership category
- akta.pro rank
WEGE KLINIK industry classification
Industry- Product category
- Oncology Hospital Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), Outpatient Care Centers (6214), Diagnostic Imaging Centers (621512)
- SIC
- Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Oncology & Cancer Specialty Hospitals (HLAFAHAC)
- akta.pro secondary industries
- Radiation Oncology (HLAKAFAC), Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)
Keywords
Where WEGE KLINIK is headquartered
LocationHeadquarters
- HQ city
- Bonn
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
WEGE KLINIK business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
Revenue model
- Inpatient Hospital Services: Stationary treatment services for cancer patients with tumor diseases, including radiotherapy, radiooncology, radiology, neuroradiology, and palliative medicine. Billed through German health insurance system (both statutory and private).
- Outpatient Clinic Services (WEGE MVZ): Ambulatory treatment services through affiliated Medical Care Center (Medizinisches Versorgungszentrum) offering radiotherapy and neurosurgery services. Outpatient care in collaboration with clinic operations.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
WEGE KLINIK product offering
Product offeringCore offering
WEGE Klinik is a specialized oncology clinic providing inpatient and outpatient radiotherapy, radiooncology, diagnostic and interventional radiology, neuroradiology, radiosurgery, brachytherapy, and palliative medicine for cancer patients with solid tumors. Services are delivered using advanced technologies including the Brainlab ExacTrac Dynamic 2.0 combined with Elekta Versa HD linear accelerator, and the Philips Spectral CT 7500 combined with CAS-One IR stereotactic navigation. The clinic accepts both statutory and private health insurance patients and operates an affiliated outpatient Medical Care Center (WEGE MVZ).
Product overview
WEGE Klinik is a specialized oncology and radiation therapy clinic offering an integrated portfolio of inpatient and outpatient services. The clinic operates as a unified system combining radiotherapy and radiation oncology (using Elekta Versa HD with Brainlab ExacTrac Dynamic 2.0), diagnostic and interventional radiology (using Philips Spectral CT 7500 with CAS-One IR stereotactic navigation), neuroradiology, radiosurgery, brachytherapy, and palliative medicine. The WEGE MVZ (Medical Care Center) provides outpatient treatment access, enabling seamless patient transitions between inpatient and ambulatory care. Unique offerings include electrochemotherapy (ECT), embolization procedures, CT-navigated fusion biopsies, and stereotactic treatments for brain, lung, prostate, and breast tumors. The clinic was historically known as Robert-Janker-Klinik and was founded in 1937, now operating under Mercurius Health Group with approximately 40-83 beds.
Differentiator
Problem solved
Functional benefit
Brands
- WEGE MVZ: Medical Care Center (Medizinisches Versorgungszentrum) providing outpatient radiotherapy and neurosurgery services
- WEGE MVZ
Products and services
- Strahlentherapie und Radioonkologie (Radiotherapy and Radiation Oncology) Comprehensive radiation therapy services for tumor treatment using external beam radiotherapy (EBRT), including IMRT, VMAT, IGRT, and stereotactic radiotherapy/radiosurgery. Delivered using the Elekta Versa HD linear accelerator combined with Brainlab ExacTrac Dynamic 2.0 for sub-millimeter positioning precision.
- Diagnostische und Interventionelle Radiologie (Diagnostic and Interventional Radiology) Diagnostic imaging and minimally invasive image-guided procedures using Philips Spectral CT 7500 combined with CAS-One IR stereotactic navigation. Enables CT-navigated fusion biopsies and precision-targeted interventions including embolization procedures.
- Neuroradiologie (Neuroradiology) Specialized diagnostic and interventional neuroradiology services for neurological conditions and brain tumor treatments, integrated with stereotactic radiosurgery capabilities.
- Radiochirurgie (Radiosurgery) High-precision stereotactic radiosurgery for brain, lung, prostate, and breast tumors using Brainlab ExacTrac Dynamic 2.0 combined with Elekta Versa HD linear accelerator, achieving sub-millimeter accuracy to protect healthy tissue.
- Palliativmedizin (Palliative Medicine) Comprehensive palliative care services focused on quality of life for seriously ill patients, including psychological support, social assistance, and specialized health training alongside medical treatment.
- Brachytherapie (Brachytherapy) Internal radiation therapy using permanent or temporary radioactive implants. Includes HDR (High Dose Rate) and LDR (Low Dose Rate) brachytherapy for prostate cancer, gynecological cancers, breast cancer, cervical cancer, and skin cancer.
- WEGE MVZ (Medical Care Center) Outpatient medical care center providing radiotherapy and neurosurgery services, enabling seamless transition between inpatient and outpatient treatment. Part of the WEGE Klinik ecosystem for combined care delivery.
- Elektrochemotherapie (Electrochemotherapy/ECT) Minimally invasive treatment where tailored tumor therapeutics are directed precisely into malignant tissue using electric shocks, maximizing protection of surrounding healthy tissue. WEGE Klinik was pioneering in developing this technology.
- Embolisation (Embolization) Minimally invasive procedures for treatment of prostate and liver diseases through targeted vascular occlusion, offered as part of interventional radiology services.
- CT-navigierte Fusionsbiopsien (CT-Navigated Fusion Biopsies) Advanced diagnostic procedure combining CT imaging with navigation technology for precise tissue sampling, enhancing accuracy of cancer diagnosis.
- Inpatient Hospital Services (Stationary Treatment) Stationary inpatient treatment services for cancer patients with tumor diseases, including radiotherapy, radiooncology, radiology, neuroradiology, and palliative medicine. Billed through the German health insurance system (both statutory and private).
Quantifiable outcome
- Sub-millimeter precision in radiation treatment positioning
- +2 more outcomes
Companies that use WEGE KLINIK
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles1 record
WEGE KLINIK technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
WEGE KLINIK partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core.
- Cascination (CAS-One IR)coreProvider of CAS-One IR stereotactic navigation system used at WEGE Klinik. WEGE Klinik is the first and only clinic in Germany combining Philips Spectral CT 7500 with Cascination's stereotactic navigation for minimally invasive oncology therapies.
- Philips (CT 7500 Spectral CT)coreProvider of Philips Spectral CT 7500 used at WEGE Klinik. WEGE Klinik is the first and only clinic in Germany combining this spectral CT with stereotactic navigation for minimally invasive therapies. Enables fifth-dimension spectral absorption imaging.
- Brainlab (ExacTrac Dynamic 2.0)coreProvider of Brainlab ExacTrac Dynamic 2.0 system combined with Elekta Versa HD at WEGE Klinik. This combination is available at only three clinics in Germany, enabling sub-millimeter precision radiotherapy.
- DEGRO (Deutsche Gesellschaft für Radioonkologie)coreGerman Society for Radiooncology. One of four professional societies accrediting the 11th Drei-Länder-Symposium für Brachytherapie in Bonn, March 2025.
- ÖGRO (Österreichische Gesellschaft für Radioonkologie)coreAustrian Society for Radiooncology. One of four professional societies accrediting the 11th Drei-Länder-Symposium für Brachytherapie in Bonn, March 2025.
- SRO/SSRO (Schweizer Gesellschaft für Radioonkologie)coreSwiss Society for Radiation Oncology. One of four professional societies accrediting the 11th Drei-Länder-Symposium für Brachytherapie in Bonn, March 2025.
- SASRO (Scientific Association of Swiss Radiation Oncology)coreScientific Association of Swiss Radiation Oncology. One of four professional societies accrediting the 11th Drei-Länder-Symposium für Brachytherapie in Bonn, March 2025.
Scale indicators5 records
Recent moves8 records
Expansion highlights6 records
WEGE KLINIK competitors and assessment
Company assessmentDirect peers
- European Institute of Oncology (IEO): Milan-based specialty oncology hospital dedicated to cancer treatment and research with a strong radiotherapy and interventional oncology focus; structurally comparable as a single-site European specialty cancer center.
- Netherlands Cancer Institute (NKI): Dutch specialty cancer hospital and research center combining inpatient oncology, radiotherapy and interventional oncology; a European benchmark for single-purpose oncology institutions and a natural peer for clinical positioning.
- Universitätsklinikum Bonn (UKB): The Bonn university hospital, a regional academic oncology and radiotherapy provider offering overlapping radiation oncology, interventional radiology and palliative services in the same catchment area; competes with WEGE for the same Bonn-area referrals and complex cases.
- Gustave Roussy: Leading European comprehensive cancer center in France combining radiation oncology, interventional procedures, brachytherapy and palliative medicine; directly comparable in scope, scale and reputation to WEGE's specialty positioning.
- Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg: Germany's flagship translational oncology center jointly run by DKFZ and Heidelberg University Hospital; comparable as a specialty oncology institution with precision radiotherapy, image-guided interventions and clinical trial leadership.
Broad incumbents
- Sana Kliniken: German private hospital group operating acute care hospitals with oncology and radiotherapy offerings; comparable as a multi-site German hospital operator with overlapping specialty services.
- Asklepios Kliniken: One of Germany's largest private hospital operators with multiple oncology and radiotherapy departments; competes for referrals and staff across Germany but lacks WEGE's single-site specialty focus.
- Charité – Universitätsmedizin Berlin: Germany's largest university hospital with comprehensive radiation oncology, interventional radiology and palliative care programs; competes for complex oncology cases and serves as a national referral and training hub.
- Helios Klinikum Bonn: Part of Helios (Quirónsalud), one of Europe's largest hospital groups; competes locally in Bonn with a broader general hospital portfolio that includes oncology and radiotherapy, but does not specialize in radiation oncology the way WEGE does.
Regional players
- MediClin AG: The former owner of the Robert-Janker-Klinik (1998–2023) and a German hospital group with oncology, radiotherapy and rehabilitation sites; overlaps with WEGE in service mix and German reimbursement exposure.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
WEGE KLINIK social profiles
Digital presenceWEGE KLINIK financial estimates
Financial estimateRevenue estimate
Valuation estimate
WEGE KLINIK leadership team
Management profileNumber of profiles
Profiles10 records
WEGE KLINIK subsidiaries and ownership
Company hierarchySubsidiaries1 record
WEGE KLINIK funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
WEGE KLINIK M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about WEGE KLINIK
What does WEGE KLINIK do?
WEGE Klinik is a specialized oncology clinic providing inpatient and outpatient radiotherapy, radiooncology, diagnostic and interventional radiology, neuroradiology, radiosurgery, brachytherapy, and palliative medicine for cancer patients with solid tumors. Services are delivered using advanced technologies including the Brainlab ExacTrac Dynamic 2.0 combined with Elekta Versa HD linear accelerator, and the Philips Spectral CT 7500 combined with CAS-One IR stereotactic navigation. The clinic accepts both statutory and private health insurance patients and operates an affiliated outpatient Medical Care Center (WEGE MVZ).
Is WEGE KLINIK a public or private company?
WEGE KLINIK is a private company. It is classified as corporate owned and is currently operating.
When was WEGE KLINIK founded?
WEGE KLINIK was founded in 1937. It employs 11 to 50 people.
Where is WEGE KLINIK based?
WEGE KLINIK is headquartered in Bonn, Germany, in the Europe region.
How does WEGE KLINIK make money?
Two revenue lines are on record. Inpatient Hospital Services are the primary driver. The others are outpatient Clinic Services (WEGE MVZ).
Who are WEGE KLINIK's main competitors?
Direct peers on record are European Institute of Oncology (IEO), Netherlands Cancer Institute (NKI), Universitätsklinikum Bonn (UKB), Gustave Roussy and Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg. Broad incumbents are Sana Kliniken, Asklepios Kliniken, Charité – Universitätsmedizin Berlin and Helios Klinikum Bonn. MediClin AG is listed as a regional player.
Does WEGE KLINIK have an API?
No public API is recorded for WEGE KLINIK.
What industry is WEGE KLINIK in?
WEGE KLINIK's product category is Oncology Hospital Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAKAFAC, Radiation Oncology. Its NAICS code is 62231 and its SIC code is 8060.